The DOI matches its Crossref record; 53 of the 55 references it cites were found in a registry or an index, and 2 are not checked yet.
Repression of RNA Polymerase I Transcription by the Tumor Suppressor p53
Open accessAbstract
The tumor suppressor protein p53 is frequently inactivated in tumors. It functions as a transcriptional activator as well as a repressor for a number of viral and cellular promoters transcribed by RNA polymerase II (Pol II) and by RNA Pol III. Moreover, it appears that p53 also suppresses RNA Pol I transcription. In this study, we examined the molecular mechanism of Pol I transcriptional inhibition by p53. We show that wild-type, but not mutant, p53 can repress Pol I transcription from a human rRNA gene promoter in cotransfection assays. Furthermore, we show that recombinant p53 inhibits rRNA transcription in a cell-free transcription system. In agreement with these results, p53-null epithelial cells display an increased Pol I transcriptional activity compared to that of epithelial cells that express p53. However, both cell lines display comparable Pol I factor protein levels. Our biochemical analysis shows that p53 prevents the interaction between SL1 and UBF. Protein-protein interaction assays indicate that p53 binds to SL1, and this interaction is mostly mediated by direct contacts with TATA-binding protein and TAF(I)110. Moreover, template commitment assays show that while the formation of a UBF-SL1 complex can partially relieve the inhibition of transcription, only the assembly of a UBF-SL1-Pol I initiation complex on the rDNA promoter confers substantial protection against p53 inhibition. In summary, our results suggest that p53 represses RNA Pol I transcription by directly interfering with the assembly of a productive transcriptional machinery on the rRNA promoter.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Induction of p53 leads to downregulation of rRNA genes212, 213 and of genes that are required for import and export of ribosomal proteins from the nucleus.214”
From Census and evaluation of p53 target genes (2017) · cites this paper as [213]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic Mutations
Cho, Y., Gorina, S., Jeffrey, P. D., & Pavletich, N. P. (1994) · Science · doi:10.1126/science.8023157 · Cited by 2,559 · cited 3×
“Plasmids for the expression of glutathione Stransferase (GST) fusion human p53 fragments, pGThp53N ( 1-160 ), pGThp53C1 (160-318), pGThp53C2 (318-393), and pGThp53C (160-393), have been described previously (24).”
Backgroundp53: puzzle and paradigm.Preprint
Ko, L. J., & Prives, C. L. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,346
Suppression of Human Colorectal Carcinoma Cell Growth by Wild-Type p53
Baker, S. J., Markowitz, S. D., Fearon, E. R., Willson, J. K. V., & Vogelstein, B. (1990) · Science · doi:10.1126/science.2144057 · Cited by 1,742
Identification of p53 as a Sequence-Specific DNA-Binding Protein
Kern, S. E., Kinzler, K. W., Bruskin, A. M., Jarosz, D., Friedman, P. N., Prives, C. L., & Vogelstein, B. (1991) · Science · doi:10.1126/science.2047879 · Cited by 1,085
[36] Eukaryotic gene transcription with purified components
Dignam, J. D., Martin, P. L., Shastry, B. S., & Roeder, R. G. (1983) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(83)01039-3 · Cited by 963
Michalovitz, D., Halevy, O., & Oren, M. (1990) · Cell · doi:10.1016/0092-8674(90)90113-s · Cited by 769
Wild-type p53 binds to the TATA-binding protein and represses transcription.
Seto, E., Usheva, A., Zambetti, G. P., Momand, J. A., Horikoshi, N., Weinmann, R. S., Levine, A. J., & Shenk, T. E. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12028 · Cited by 504
p53 Transcriptional Activation Mediated by Coactivators TAF II 40 and TAF II 60
Thut, C. J., Chen, J.-L., Klemm, R. D., & Tjian, R. (1995) · Science · doi:10.1126/science.7809597 · Cited by 439
Cited by
Sorted by citations
Boulon, S., Westman, B. J., Hutten, S., Boisvert, F.-M., & Lamond, A. I. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.024 · Cited by 1,103
Census and evaluation of p53 target genes
Fischer, M. (2017) · Oncogene · doi:10.1038/onc.2016.502 · Cited by 971
Does the ribosome translate cancer?
Ruggero, D., & Pandolfi, P. P. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1015 · Cited by 953
Rubbi, C. P., & Milner, J. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg579 · Cited by 828
Ribosomal proteins: functions beyond the ribosome
Zhou, X. Y., Liao, W.-J., Liao, J., Liao, P., & Lu, H. (2015) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjv014 · Cited by 772
Regulation of HDM2 activity by the ribosomal protein L11
Lohrum, M. A. E., Ludwig, R. L., Kubbutat, M. H. G., Hanlon, M., & Vousden, K. H. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00134-x · Cited by 626
Drygin, D., Lin, A. H., Bliesath, J., Ho, C., O’Brien, S., Proffitt, C., Omori, M., Haddach, M., Schwaebe, M. K., Siddiqui-Jain, A., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1728 · Cited by 626
Divorcing ARF and p53: an unsettled case
Sherr, C. J. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1954 · Cited by 595
Anticancer Activity of CX-3543: A Direct Inhibitor of rRNA Biogenesis
Drygin, D., Siddiqui-Jain, A., O’Brien, S., Schwaebe, M. K., Lin, A. H., Bliesath, J., Ho, C., Proffitt, C., Trent, K., Whitten, J. P., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1304 · Cited by 612
The expanding universe of p53 targets
Menendez, D., Inga, A., & Resnick, M. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2730 · Cited by 568
Transcriptional Regulation by P53
Beckerman, R., & Prives, C. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000935 · Cited by 569
Life on a planet of its own: Regulation of RNA polymerase I transcription in the nucleolus
Grummt, I. (2003) · Genes & Development · doi:10.1101/gad.1098503r · Cited by 540
Transcriptional regulation by p53: one protein, many possibilities
Laptenko, O., & Prives, C. L. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401916 · Cited by 515
Dai, M., Zeng, S. X., Jin, Y., Sun, X., David, L. L., & Lu, H. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.17.7654-7668.2004 · Cited by 495
Chemotherapeutic Drugs Inhibit Ribosome Biogenesis at Various Levels
Burger, K., Mühl, B., Thomas, H., Michaela, R., Anastassia, M., Orban, M., Kellner, M., Anita, G.-E., Kremmer, E., Hölzel, M., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.074211 · Cited by 448
Nucleolus, Ribosomes, and Cancer
Montanaro, L., Treré, D., & Derenzini, M. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.070752 · Cited by 456
Prevention of the neurocristopathy Treacher Collins syndrome through inhibition of p53 function
Jones, N. C., Lynn, M. L., Gaudenz, K., Sakai, D., Aoto, K., Rey, J., Glynn, E. F., Ellington, L. R., Du, C., Dixon, J., et al. (2008) · Nature Medicine · doi:10.1038/nm1725 · Cited by 440
The RNA Polymerase I Transcription Machinery: An Emerging Target for the Treatment of Cancer
Drygin, D., Rice, W. G., & Grummt, I. (2010) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105844 · Cited by 439
Marcel, V., Ghayad, S. E., Belin, S., Thérizols, G., Morel, A., Solano-Gonzàlez, E., Vendrell, J. A., Hacot, S., Mertani, H. C., Albaret, M. A., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.08.013 · Cited by 394
RNA polymerases I and III, growth control and cancer
White, R. J. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1551 · Cited by 342
French, S. L., Osheim, Y. N., Cioci, F., Nomura, M., & Beyer, A. L. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.5.1558-1568.2003 · Cited by 325
Ribosome Biogenesis: A Central Player in Cancer Metastasis and Therapeutic Resistance
Elhamamsy, A. R., Metge, B. J., Alsheikh, H. A., Shevde, L. A., & Samant, R. S. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-4087 · Cited by 320
A Targeting Modality for Destruction of RNA Polymerase I that Possesses Anticancer Activity
Peltonen, K., Colis, L. C., Liu, H., Trivedi, R. K., Moubarek, M. S., Moore, H. M., Bai, B., Rudek, M. A., Bieberich, C. J., & Laiho, M. (2014) · Cancer Cell · doi:10.1016/j.ccr.2013.12.009 · Cited by 327
A housekeeper with power of attorney: the rRNA genes in ribosome biogenesis
Moss, T., Langlois, F., Gagnon-Kugler, T., & Stefanovsky, V. Y. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6278-1 · Cited by 310
Ribosome biogenesis surveillance: probing the ribosomal protein-Mdm2-p53 pathway
Deisenroth, C., & Zhang, Y. (2010) · Oncogene · doi:10.1038/onc.2010.189 · Cited by 301
Nucleolar Arf Tumor Suppressor Inhibits Ribosomal RNA Processing
Sugimoto, M., Kuo, M.-L., Roussel, M. F., & Sherr, C. J. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00057-1 · Cited by 273
What the nucleolus says to a tumour pathologist
Derenzini, M., Montanaro, L., & Treré, D. (2009) · Histopathology · doi:10.1111/j.1365-2559.2008.03168.x · Cited by 271
The nucleolus: an emerging target for cancer therapy
Hein, N., Hannan, K. M., George, A. J., Sanij, E., & Hannan, R. D. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.07.005 · Cited by 259
Wang, X., Kua, H.-Y., Hu, Y., Guo, K., Zeng, Q., Wu, Q., Ng, H., Karsenty, G., Crombrugghe, B. D., Yeh, J. K., et al. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200507106 · Cited by 254
p53 and ribosome biogenesis stress: The essentials
Golomb, L., Volarević, S., & Oren, M. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.04.014 · Cited by 254
Stefanovsky, V. Y., Pelletier, G., Hannan, R. D., Gagnon-Kugler, T., Rothblum, L. I., & Moss, T. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00384-7 · Cited by 242
Targeting the nucleolus for cancer intervention
Quin, J. E., Devlin, J. R., Cameron, D. P., Hannan, K. M., Pearson, R. B., & Hannan, R. D. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.12.009 · Cited by 230
Wang, W., Nag, S. A., Zhang, X., Wang, M., Wang, H., Zhou, J., & Zhang, R. (2014) · Medicinal Research Reviews · doi:10.1002/med.21327 · Cited by 232
Dysregulation of the basal RNA polymerase transcription apparatus in cancer
Bywater, M. J., Pearson, R. B., McArthur, G. A., & Hannan, R. D. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3496 · Cited by 224
Impaired ribosome biogenesis: mechanisms and relevance to cancer and aging
Turi, Z., Lacey, M., Mistrík, M., & Moudrý, P. (2019) · Aging · doi:10.18632/aging.101922 · Cited by 220
At the Center of Eukaryotic Life
Moss, T., & Stefanovsky, V. Y. (2002) · Cell · doi:10.1016/s0092-8674(02)00761-4 · Cited by 215
Conventional and nonconventional roles of the nucleolus
Olson, M. O. J., Hingorani, K., & Szebeni, A. (2002) · International review of cytology · doi:10.1016/s0074-7696(02)19014-0 · Cited by 215
RNA polymerase III transcription and cancer
White, R. J. (2004) · Oncogene · doi:10.1038/sj.onc.1207547 · Cited by 207
Basic mechanisms in RNA polymerase i transcription of the ribosomal RNA genes
Goodfellow, S. J., & Zomerdijk, J. C. B. M. (2013) · Subcellular Biochemistry · doi:10.1007/978-94-007-4525-4_10 · Cited by 197
RNA polymerases I and III, non-coding RNAs and cancer
White, R. J. (2008) · Trends in Genetics · doi:10.1016/j.tig.2008.10.003 · Cited by 190
How Ribosomes Translate Cancer
Sulima, S. O., Hofman, I. J., Keersmaecker, K. D., & Dinman, J. D. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0550 · Cited by 185
IMP dehydrogenase-2 drives aberrant nucleolar activity and promotes tumorigenesis in glioblastoma
Kofuji, S., Hirayama, A., Eberhardt, A. O., Kawaguchi, R. K., Sugiura, Y., Sampetrean, O., Ikeda, Y., Warren, M., Sakamoto, N., Kitahara, S., et al. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0363-9 · Cited by 171
Haddach, M., Schwaebe, M. K., Michaux, J., Nagasawa, J. Y., O’Brien, S., Whitten, J. P., Pierre, F., Kerdoncuff, P., Darjania, L., Stansfield, R. K., et al. (2012) · ACS Medicinal Chemistry Letters · doi:10.1021/ml300110s · Cited by 165
Regulation of NF‐κB and p53 through activation of ATR and Chk1 by the ARF tumour suppressor
Rocha, S., Garrett, M. D., Campbell, K. J., Schumm, K., & Perkins, N. D. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600608 · Cited by 161
miR-10 in development and cancer
Lund, A. H. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.58 · Cited by 165
At the crossroads of growth control; making ribosomal RNA
Moss, T. (2004) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2004.02.005 · Cited by 156
Ribosomes and marrow failure: coincidental association or molecular paradigm?
Liu, J. M., & Ellis, S. R. (2006) · Blood · doi:10.1182/blood-2005-12-4831 · Cited by 159
The nucleolus and transcription of ribosomal genes
Raška, I., Koberna, K., Malínský, J., Fidlerová, H., & Mašata, M. (2004) · Biology of the Cell · doi:10.1016/j.biolcel.2004.04.015 · Cited by 165
Crighton, D., Woiwode, A., Zhang, C., Mandavia, N., Morton, J. P., Warnock, L. J., Milner, J., White, R. J., & Johnson, D. L. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg265 · Cited by 141
Dysregulation of RNA polymerase I transcription during disease
Hannan, K. M., Sanij, E., Rothblum, L. I., Hannan, R. D., & Pearson, R. B. (2012) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2012.10.014 · Cited by 137
Importin 7 and Exportin 1 Link c-Myc and p53 to Regulation of Ribosomal Biogenesis
Golomb, L., Bublik, D. R., Wilder, S., Nevo, R., Kiss, V., Grabusic, K., Volarevic, S., & Oren, M. (2012) · Molecular Cell · doi:10.1016/j.molcel.2011.11.022 · Cited by 137
Regulation of ribosome biogenesis within the nucleolus
Leary, D. J., & Huang, S. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)03143-x · Cited by 132
Li, F., Li, G., Liu, G., Lee, S. W., & Aaronson, S. A. (2001) · The EMBO Journal · doi:10.1093/emboj/20.8.1931 · Cited by 131
Cancer nucleus: Morphology and beyond
Dey, P. (2009) · Diagnostic Cytopathology · doi:10.1002/dc.21234 · Cited by 129
Wang, M., & Lemos, B. (2017) · PLoS Genetics · doi:10.1371/journal.pgen.1006994 · Cited by 129
Kao, C.-F., Chen, S.-Y., Chen, J., & Lee, Y. W. (2004) · Oncogene · doi:10.1038/sj.onc.1207368 · Cited by 129
The ribosome, (slow) beating heart of cancer (stem) cell
Bastide, A., & David, A. (2018) · Oncogenesis · doi:10.1038/s41389-018-0044-8 · Cited by 125
Ribosome biogenesis and cancer
Derenzini, M., Montanaro, L., & Treré, D. (2017) · Acta Histochemica · doi:10.1016/j.acthis.2017.01.009 · Cited by 128
Ribosomopathies: Global process, tissue specific defects
Yelick, P. C., & Trainor, P. A. (2015) · Rare Diseases · doi:10.1080/21675511.2015.1025185 · Cited by 117
The nucleolus as a fundamental regulator of the p53 response and a new target for cancer therapy
Woods, S. J., Hannan, K. M., Pearson, R. B., & Hannan, R. D. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.10.007 · Cited by 120
Ho, Y., & Gasch, A. P. (2015) · Current Genetics · doi:10.1007/s00294-015-0491-0 · Cited by 110
Regulation of RNA Polymerase I Transcription in Development, Disease, and Aging
Sharifi, S., & Bierhoff, H. (2018) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-062917-012612 · Cited by 108
LAS1L interacts with the mammalian Rix1 complex to regulate ribosome biogenesis
Castle, C. D., Cassimere, E. K., & Denicourt, C. (2011) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-06-0530 · Cited by 109
Signal Transduction in Ribosome Biogenesis: A Recipe to Avoid Disaster
Piazzi, M., Bavelloni, A., Gallo, A., Faenza, I., & Blalock, W. L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112718 · Cited by 109
PTEN Represses RNA Polymerase I Transcription by Disrupting the SL1 Complex
Zhang, C., Comai, L., & Johnson, D. L. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.16.6899-6911.2005 · Cited by 101
Self-citationHE4 (WFDC2) gene overexpression promotes ovarian tumor growth
Moore, R. G., Hill, E. K., Horan, T. C., Yano, N., Kim, K., MacLaughlan, S. D., Lambert-Messerlian, G. M., Tseng, Y., Padbury, J. F., Miller, M. C., et al. (2014) · Scientific Reports · doi:10.1038/srep03574 · Cited by 100
Regulation of the p53 transcriptional activity
Liu, G., & Chen, X. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20700 · Cited by 100
Arf induces p53-dependent and -independent antiproliferative genes.
Kuo, M.-L., Duncavage, E. J., Mathew, R., den Besten, W., Pei, D., Naeve, D., Yamamoto, T. S., Cheng, C., Sherr, C. J., & Roussel, M. F. (2003) · PubMed · Cited by 99
Donati, G., Bertoni, S., Brighenti, E., Vici, M., Treré, D., Volarević, S., Montanaro, L., & Derenzini, M. (2011) · Oncogene · doi:10.1038/onc.2011.48 · Cited by 100
Suppression of Cardiomyocyte Hypertrophy by Inhibition of the Ubiquitin-Proteasome System
Meiners, S., Dreger, H., Fechner, M., Bieler, S., Rother, W., Günther, C., Baumann, G., Stangl, V., & Stangl, K. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.097816 · Cited by 98
Guarding the ‘translation apparatus’: defective ribosome biogenesis and the p53 signaling pathway
Chakraborty, A., Uechi, T., & Kenmochi, N. (2011) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.73 · Cited by 100
Grewal, S. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.12.005 · Cited by 97
Montanaro, L., Treré, D., & Derenzini, M. (2011) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2011.10.006 · Cited by 98
Connecting the nucleolus to the cell cycle and human disease
Tsai, R. Y. L., & Pederson, T. (2014) · The FASEB Journal · doi:10.1096/fj.14-254680 · Cited by 98
Horton, L. E., Bushell, M., Baus, D., Tilleray, V. J., Clemens, M. J., & Hensold, J. O. (2002) · Oncogene · doi:10.1038/sj.onc.1205662 · Cited by 94
Barkić, M., Crnomarković, S., Grabušić, K., Bogetić, I., Panić, L., Tamarut, S., Brdovčak, M. C., Jerić, I., Vidak, S., & Volarević, S. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01588-08 · Cited by 92
Ribosomal DNA and the Nucleolus as Keystones of Nuclear Architecture, Organization, and Function
Cerqueira, A. V., & Lemos, B. (2019) · Trends in Genetics · doi:10.1016/j.tig.2019.07.011 · Cited by 94
Small Molecule BMH-Compounds That Inhibit RNA Polymerase I and Cause Nucleolar Stress
Peltonen, K., Colis, L. C., Liu, H., Jäämaa, S., Zhang, Z., af Hällström, T., Moore, H. M., Sirajuddin, P., & Laiho, M. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0256 · Cited by 90
p53 Represses the Oncogenic Sno-MiR-28 Derived from a SnoRNA
Yu, F., Bracken, C. P., Pillman, K. A., Lawrence, D., Goodall, G. J., Callen, D. F., & Neilsen, P. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129190 · Cited by 92
p8-deficient fibroblasts grow more rapidly and are more resistant to adriamycin-induced apoptosis
Vasseur, S., Hoffmeister, A., García‐Montero, A. C., Mallo, G. V., Feil, R., Kühbandner, S., Dagorn, J., & Iovanna, J. (2002) · Oncogene · doi:10.1038/sj.onc.1205222 · Cited by 89
p53, a translational regulator: contribution to its tumour-suppressor activity
Marcel, V., Catez, F., & Diaz, J. (2015) · Oncogene · doi:10.1038/onc.2015.25 · Cited by 94
Srivenugopal, K. S., Shou, J., Mullapudi, S., Lang, F. F., Rao, J. S., & Ali‐Osman, F. (2001) · PubMed · Cited by 88
Schneider, D. A. (2011) · Gene · doi:10.1016/j.gene.2011.08.006 · Cited by 87
p53 activation during ribosome biogenesis regulates normal erythroid differentiation
Goff, S. L., Boussaid, I., Floquet, C., Raimbault, A., Hatin, I., Andrieu‐Soler, C., Salma, M., Leduc, M., Gautier, E., Guyot, B., et al. (2020) · Blood · doi:10.1182/blood.2019003439 · Cited by 85
Rrn3 Phosphorylation Is a Regulatory Checkpoint for Ribosome Biogenesis
Cavanaugh, A. H., Hirschler‐Laszkiewicz, I., Hu, Q., Dundr, M., Smink, T., Misteli, T., & Rothblum, L. I. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201232200 · Cited by 86
Ribosomal proteins as novel players in tumorigenesis
Heras-Rubio, A. D. L., Perucho, L., Paciucci, R., Vilardell, J., & LLeonart, M. E. (2013) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9460-6 · Cited by 87
The Nucleolus: In Genome Maintenance and Repair
Tsekrekou, M., Stratigi, K., & Chatzinikolaou, G. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071411 · Cited by 86
Cancer Biogenesis in Ribosomopathies
Sulima, S. O., Kampen, K. R., & Keersmaecker, K. D. (2019) · Cells · doi:10.3390/cells8030229 · Cited by 93
Nucleolar Size and Activity Are Related to pRb and p53 Status in Human Breast Cancer
Treré, D., Ceccarelli, C., Montanaro, L., Tosti, E., & Derenzini, M. (2004) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.4a6454.2004 · Cited by 85
Methylation of the ribosomal RNA gene promoter is associated with aging and age‐related decline
D’Aquila, P., Montesanto, A., Mandalà, M., Garasto, S., Mari, V., Corsonello, A., Bellizzi, D., & Passarino, G. (2017) · Aging Cell · doi:10.1111/acel.12603 · Cited by 84
Ayrault, O., Andrique, L., Fauvin, D., Eymin, B., Gazzéri, S., & Seité, P. (2006) · Oncogene · doi:10.1038/sj.onc.1209743 · Cited by 84
Therapeutic Approaches Targeting Nucleolus in Cancer
Carotenuto, P., Pecoraro, A., Palma, G., Russo, G., & Russo, A. (2019) · Cells · doi:10.3390/cells8091090 · Cited by 81
Transcriptional Repression: Conserved and Evolved Features
Payankaulam, S., Li, L. M., & Arnosti, D. N. (2010) · Current Biology · doi:10.1016/j.cub.2010.06.037 · Cited by 79
Emerging Role of Eukaryote Ribosomes in Translational Control
Venezia, N. D., Vincent, A., Marcel, V., Catez, F., & Diaz, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20051226 · Cited by 85
Scission of the p53-MDM2 Loop by Ribosomal Proteins
Zhou, X. Y., Liao, J.-M., Liao, W.-J., & Lu, H. (2012) · Genes & Cancer · doi:10.1177/1947601912455200 · Cited by 82
Porter, J. R., Fisher, B. E., Baranello, L., Liu, J. C., Kambach, D. M., Nie, Z., Koh, W. S., Luo, J., Stommel, J. M., Levens, D., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.07.028 · Cited by 79
Mechanisms of translational deregulation in human tumors and therapeutic intervention strategies
Bilanges, B., & Stokoe, D. (2007) · Oncogene · doi:10.1038/sj.onc.1210431 · Cited by 81
Las1L Is a Nucleolar Protein Required for Cell Proliferation and Ribosome Biogenesis
Castle, C. D., Cassimere, E. K., Lee, J., & Denicourt, C. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00358-10 · Cited by 75
The Evolution of the Ribosomal Protein–MDM2–p53 PathwayPreprint
Deisenroth, C., Franklin, D. A., & Zhang, Y. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026138 · Cited by 71
Baltanás, F. C., Casafont, Í., Weruaga, E., Alonso, J. R., Berciano, M. T., & Lafarga, M. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2010.00461.x · Cited by 73
Metadata
- Authors
- Zhai, W., & Comai, L.
- Affiliations
- University of Southern California (US)
- Corresponding author
- Comai, Lucio
- ORCID
- Comai, Lucio
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2000-08
- Volume
- 20
- Issue
- 16
- Pages
- 5930-5938
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC86070
- OpenAlex
- W2146842824
- Cited by
- 289
- References
- 53
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 8 · 2023: 9 · 2022: 10 · 2021: 14 · 2020: 7 · 2019: 14 · 2018: 13 · 2017: 13 · 2016: 6 · 2015: 14 · 2014: 24 · 2013: 21 · 2012: 7
- FWCI
- 2.53
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Molecular and Cellular Biology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of General Medical Sciences (R01GM053949, R01 GM53949)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Structure and Function
- Keywords
- p53, RNA polymerase I transcription, transcriptional repression, UBF, TATA-binding protein, protein-protein interaction, transcription initiation complex, tumor suppressor
- MeSH terms
- HeLa Cells, Humans, Plasmids, RNA Polymerase I, Transcription, Genetic, Transfection, Genes, Tumor Suppressor, Genes, p53, Tumor Suppressor Protein p53
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review